Granules India promoter sells 1.72 crore shares in block deal
- Promoter Dr. Krishna Prasad Chigurupati sold 1,72,00,000 shares via block deal on September 11, 2026
- Stake reduced from 31.00% to 24.06% of total voting capital
- Institutional buyers included Capital Group, Kotak Life, and ChrysCapital
- Post-sale holding stands at 5,96,08,111 shares (21.85% diluted)

*this image is generated using AI for illustrative purposes only.
Granules India Limited promoter Dr. Krishna Prasad Chigurupati disposed of 1,72,00,000 equity shares through a block deal on September 11, 2026. The transaction represented 6.94% of the company’s total voting capital.
The sale reduced Chigurupati’s stake in the Hyderabad-based pharmaceutical firm from 31.00% to 24.06%. Prior to the transaction, he held 7,68,08,111 shares carrying voting rights.
Transaction Details
The block deal saw participation from marquee institutional investors. Buyers included Capital Group, Kotak Mahindra Life Insurance Company, ChrysCapital, Allspring, and other domestic and global entities.
| Metric | Before Sale | Shares Sold | After Sale |
|---|---|---|---|
| Shares Held | 7,68,08,111 | 1,72,00,000 | 5,96,08,111 |
| Stake (% of Voting Capital) | 31.00% | 6.94% | 24.06% |
| Diluted Stake (%) | 28.16% | 6.31% | 21.85% |
Chigurupati filed the disclosure under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The filing was submitted to the National Stock Exchange of India Limited and BSE Limited.
What the Numbers Show
The promoter’s post-transaction holding of 5,96,08,111 shares represents a significant reduction in concentration risk for institutional buyers. While the absolute stake dropped by nearly seven percentage points, Chigurupati retains control with a diluted holding of 21.85%, remaining the largest single shareholder group as no other entity was disclosed as acquiring a controlling interest in this specific transaction.
Historical Stock Returns for Granules
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.12% | +6.49% | +6.33% | +56.43% | +73.32% | 0.0% |
How might the entry of marquee institutional investors like Capital Group and Allspring influence Granules India's corporate governance and strategic decision-making?
What are the potential implications for Granules India's stock price volatility given the significant reduction in promoter concentration risk?
Could this block deal signal the promoter's intent to raise capital for future acquisitions or debt reduction, and how might that impact the company's balance sheet?


































